SCHEMBL8428973

SCHEMBL8428973

Cc1ccc(F)c(F)c1C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.39
HDAC4 P56524 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 1/20 0.33
TSHR P16473 1/20 0.33
TDP2 O95551 1/20 0.33
NSD2 O96028 1/20 0.33
HSP90AA1 P07900 1/20 0.33
PAX8 Q06710 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
PTGS2 P35354 4/20 0.33
PTGS1 P23219 1/20 0.32
POLB P06746 1/20 0.31
TRPA1 O75762 1/20 0.31
ATM Q13315 1/20 0.31
RAPGEF4 Q8WZA2 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144695 0.81 ACHE (0.36) ACHEHDAC4CYP1A2CYP2A6TSHR
SCHEMBL31633781 0.81 ACHE (0.36) ACHEHDAC4CYP1A2CYP2A6TSHR
SCHEMBL172114 0.81 ACHE (0.36) ACHEHDAC4CES2CES1
SCHEMBL13905953 0.80 ACHE (0.38) ACHECYP1A2CYP2A6TSHRTDP2
SCHEMBL31633778 0.79 ACHE (0.41) ACHECYP1A2CYP2A6TSHRTDP2
SCHEMBL67359 0.79 ACHE (0.41) ACHEHDAC4CYP1A2CES2CES1
SCHEMBL3475177 0.79 ACHE (0.41) ACHECYP1A2CYP2A6TSHRTDP2
SCHEMBL175646 0.79 ACHE (0.41) ACHEHDAC4CYP1A2CES2CES1
SCHEMBL10595967 0.78 ACHE (0.36) ACHECES2CES1PTGS2PTGS1
SCHEMBL4549537 0.77 ACHE (0.39) ACHECYP1A2POLBRAPGEF4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240217971-A1 PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE Université de Montréal (CA) 2024-07-04 US disclosed
US-20240217971-A1 PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE Université de Montréal (CA) 2024-07-04 US disclosed
WO-2024077391-A1 THIAZOLO[5,4-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2024-04-18 WO disclosed
US-11916180-B2 Organic solar cell and photodetector materials and devices THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-02-27 US disclosed
US-11916180-B2 Organic solar cell and photodetector materials and devices THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-02-27 US disclosed
US-20230286961-A1 SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2023-09-14 US disclosed
US-20230263056-A1 ORGANIC SOLAR CELL AND PHOTODETECTOR MATERIALS AND DEVICES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-08-17 US disclosed
US-20230227437-A1 IMMUNOMODULATOR HITGEN INC (CN) 2023-07-20 US disclosed
US-20090174316-A1 Novel red electroluminescent compounds and organi electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-07-09 US disclosed
US-20090145483-A1 Novel electroluminescent compounds and organic electroluminescent device suing the same GRACEL DISPLAY INC. (KR) 2009-06-11 US disclosed
EP-2066150-A1 Novel red electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-06-03 EP disclosed
EP-2003131-A1 AMINOPYRROLIDINE COMPOUND Taisho Pharmaceutical Co. Ltd. (JP) 2008-12-17 EP disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed
US-5968868-A Catalyst for use in the alkylation of isoalkanes NIPPON OIL CO., LTD. (JP) 1999-10-19 US disclosed
EP-0285324-B1 PREPARATION OF SUBSTITUTED FLUOROBENZENES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-11-27 EP disclosed
EP-0285324-A1 Preparation of substituted fluorobenzenes E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-10-05 EP disclosed
US-4754084-A PYROLYSIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286961-A1 SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS TRPV1, TRPA1, SCN2B ACHE 856/4885HDAC4 1029/4885CYP1A2 1919/4885
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO ACHE 3530/4885HDAC4 1930/4885CYP1A2 4680/4885
US-20090145483-A1 Novel electroluminescent compounds and organic electroluminescent device suing the same LEF1, ODC1, AOC2 ACHE 1498/4885HDAC4 4238/4885CYP1A2 1920/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX ACHE 2596/4885HDAC4 1262/4885CYP1A2 1811/4885
US-20230227437-A1 IMMUNOMODULATOR IL17A, IL2, IL2RA ACHE 4158/4885HDAC4 1719/4885CYP1A2 274/4885
US-20230263056-A1 ORGANIC SOLAR CELL AND PHOTODETECTOR MATERIALS AND DEVICES OCIAD1, OCIAD2, CDH1 ACHE 4455/4885HDAC4 3469/4885CYP1A2 2695/4885
US-20090174316-A1 Novel red electroluminescent compounds and organi electroluminescent device using the same ALPI, IK, ALDH1A2 ACHE 1921/4885HDAC4 4481/4885CYP1A2 2596/4885
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS ACHE 4868/4885HDAC4 3489/4885CYP1A2 2650/4885
US-11916180-B2 Organic solar cell and photodetector materials and devices OCIAD1, OCIAD2, CDH1 ACHE 4455/4885HDAC4 3469/4885CYP1A2 2695/4885
US-20240217971-A1 PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE BRAF, NRAS, DPYD ACHE 4854/4885HDAC4 3058/4885CYP1A2 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.